Thursday , November 23 2017
Home / Specialties / Podiatry / Dr. Don Fetterolf, Part 1: Prevalence of Diabetic Foot Ulcers

Dr. Don Fetterolf, Part 1: Prevalence of Diabetic Foot Ulcers

In part one of this interview on the use of amniotic membrane as a possible treatment for diabetic ulcers, Diabetes in Control publisher first talks with Dr. Don Fetterolf about the prevalence of diabetic foot ulcers, the impact of the condition and the groups who are affected.

Dr. Fetterolf  is the Chief Medical Officer of MiMedx Group, Inc. a bioengineering and regenerative medicine company that is an integrated developer, manufacturer and marketer of biomaterial-based products in the United States and multiple foreign countries. Dr. Fetterolf is an experienced physician executive with extensive expertise in clinical medicine, health care business management, and medical informatics.

Featuring